30 PHARMA

We are advancing research using 30Technology™ to enhance the passage of molecules across the skin barrier.

RESEARCH PRIORITIES

TRANSDERMAL

As well as stimulating local vasodilation, NO regulates intercellular adhesion and increases blood vessel permeability. 30Technology™ allows the transdermal application of large molecules that cannot currently be administered across the skin barrier, thus avoiding pre-systemic metabolism that may occur following oral dosing, including both intestinal and hepatic first-pass metabolism.

SEPTIC SHOCK

Septic shock, as seen as a severe complication in paediatric meningitis, may cause severe reduction of microcirculatory blood flow which, if a patient survives, can lead to permanent loss of limb function and extremity amputation.

30 TECHNOLOGY is developing and defining new models of care to treat many serious medical conditions by enhancing the body’s healing and defence mechanisms.

30 TECHNOLOGY Therapeutic Nitric Oxide